Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 4/20 | 0.45 |
| ▸ | CTSD | P07339 | 1/20 | 0.45 |
| ▸ | FASN | P49327 | 8/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.35 |
| ▸ | TAB1 | Q15750 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7551495 | 0.91 | BACE1 (0.43) | BACE1CTSDFASNKMT2ABRD4 | |
| SCHEMBL2969011 | 0.90 | BACE1 (0.42) | BACE1CTSDFASNKMT2ABRD4 | |
| SCHEMBL7537950 | 0.90 | BACE1 (0.42) | BACE1CTSDFASNKMT2ABRD4 | |
| SCHEMBL7566169 | 0.89 | BACE1 (0.43) | BACE1CTSDFASNKMT2ABRD4 | |
| SCHEMBL7544375 | 0.89 | BACE1 (0.53) | BACE1CTSDFASNKMT2ABRD4 | |
| SCHEMBL7541064 | 0.89 | CTSD (0.42) | BACE1CTSDFASNKMT2ABRD4 | |
| SCHEMBL7546538 | 0.89 | BACE1 (0.48) | BACE1CTSDFASNKMT2ABRD4 | |
| SCHEMBL7544570 | 0.89 | BACE1 (0.41) | BACE1CTSDFASNKMT2ABRD4 | |
| SCHEMBL7532513 | 0.88 | BRD4 (0.42) | BACE1CTSDFASNBRD4 | |
| SCHEMBL7544582 | 0.88 | BACE1 (0.50) | BACE1CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006065277-A2 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS | SCHERING CORPORATION (US) | 2006-06-22 | — | — | WO | disclosed |